Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes
Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastati...
Gespeichert in:
Veröffentlicht in: | The American journal of surgical pathology 2016-03, Vol.40 (3), p.404-409 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 409 |
---|---|
container_issue | 3 |
container_start_page | 404 |
container_title | The American journal of surgical pathology |
container_volume | 40 |
creator | Hussein, Yaser R Ducie, Jennifer A Arnold, Angela G Kauff, Noah D Vargas-Alvarez, Hebert A Sala, Evis Levine, Douglas A Soslow, Robert A |
description | Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastatic HGSC-BRCA cases. Of the 37 cases of advanced-stage HGSC with known BRCA1 or BRCA2 germline mutation retrieved from our institutional files, 23 patients had a germline mutation of BRCA1 and 14 had a BRCA2 mutation. The pattern of invasion at metastatic sites was recorded and classified as a pushing pattern (either predominantly or exclusively), an exclusively micropapillary infiltrative pattern, or an infiltrative pattern composed of papillae, micropapillae, glands, and nests (mixed infiltrative pattern). Histologic evaluation of metastases was performed without knowledge of genotype or clinical outcome. Clinical data were abstracted from medical records. Median age was 56 years (range, 31 to 73 y). All patients presented at stage IIIC or IV and underwent complete surgical staging followed by chemotherapy. All 37 HGSC-BRCA cases showed either pushing pattern metastases (30; 81%) or infiltrative micropapillary metastases (7; 19%). No HGSC-BRCA case exhibited metastases composed solely of mixed infiltrative patterns. Among the 7 infiltrative micropapillary cases, 6 had a BRCA1 germline mutation versus 1 with a BRCA2 mutation. The median time of follow-up was 26 months (range, 13 to 49 mo). All 7 patients with infiltrative micropapillary metastases either experienced recurrence or died of disease (5 recurrences and 2 deaths), which was significantly worse than what was seen in patients with predominantly pushing pattern metastases, of whom 16 of 30 (53%) experienced recurrence (n=14) or died of disease (n=2) (P=0.03). In conclusion, the recognition of different invasion patterns of metastatic extrauterine HGSC-BRCA has prognostic implications. The infiltrative micropapillary pattern is associated with poor outcomes and is more frequently seen in BRCA1-associated HGSC than in BRCA2 cases. |
doi_str_mv | 10.1097/PAS.0000000000000556 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1765112935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5786-2fdac4e62a92e9fab937e531bcf1d7411fd887a4601637c9c58c89d6ffb162423</originalsourceid><addsrcrecordid>eNp9kc9OFTEUhxujkSv4BsZ06WZw2umfmY3JdYJAAoEIhGXT2zlzp9qZYtsBeQZe2l4vEnRhN01zvvOdtj-E3pFyn5SN_Hi-vNgvny_OxQu0ILyiRa43L9GiJEwWnNR8B72J8VtZEloT-hrtUMElqxlfoIfj6VZH6yd8rlOCMEXse3wKScekkzX44GcKes4VOwE-suuhWAfdAb6A4OeIWx2Mnfyo8bVNA_78tV3iQwij2-Cn88aR3XrqcOtDALc9_2bbzFijHT6bk_EjxD30qtcuwtvHfRddfTm4bI-Kk7PD43Z5Uhgua1HQvtOGgaC6odD0etVUEnhFVqYnnWSE9F1dS81ESUQlTWN4beqmE32_IoIyWu2iT1vvzbwaoTMw5Sc6dRPsqMO98tqqvyuTHdTa3yrWyJJRkQUfHgXB_5ghJjXaaMA5PUH-FEWk4ITQpuIZZVvUBB9jgP5pDCnVJkeVc1T_5pjb3j-_4lPTn-AyUG-BO-9yOPG7m-8gqAG0S8P_3b8An6etBA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1765112935</pqid></control><display><type>article</type><title>Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Hussein, Yaser R ; Ducie, Jennifer A ; Arnold, Angela G ; Kauff, Noah D ; Vargas-Alvarez, Hebert A ; Sala, Evis ; Levine, Douglas A ; Soslow, Robert A</creator><creatorcontrib>Hussein, Yaser R ; Ducie, Jennifer A ; Arnold, Angela G ; Kauff, Noah D ; Vargas-Alvarez, Hebert A ; Sala, Evis ; Levine, Douglas A ; Soslow, Robert A</creatorcontrib><description>Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastatic HGSC-BRCA cases. Of the 37 cases of advanced-stage HGSC with known BRCA1 or BRCA2 germline mutation retrieved from our institutional files, 23 patients had a germline mutation of BRCA1 and 14 had a BRCA2 mutation. The pattern of invasion at metastatic sites was recorded and classified as a pushing pattern (either predominantly or exclusively), an exclusively micropapillary infiltrative pattern, or an infiltrative pattern composed of papillae, micropapillae, glands, and nests (mixed infiltrative pattern). Histologic evaluation of metastases was performed without knowledge of genotype or clinical outcome. Clinical data were abstracted from medical records. Median age was 56 years (range, 31 to 73 y). All patients presented at stage IIIC or IV and underwent complete surgical staging followed by chemotherapy. All 37 HGSC-BRCA cases showed either pushing pattern metastases (30; 81%) or infiltrative micropapillary metastases (7; 19%). No HGSC-BRCA case exhibited metastases composed solely of mixed infiltrative patterns. Among the 7 infiltrative micropapillary cases, 6 had a BRCA1 germline mutation versus 1 with a BRCA2 mutation. The median time of follow-up was 26 months (range, 13 to 49 mo). All 7 patients with infiltrative micropapillary metastases either experienced recurrence or died of disease (5 recurrences and 2 deaths), which was significantly worse than what was seen in patients with predominantly pushing pattern metastases, of whom 16 of 30 (53%) experienced recurrence (n=14) or died of disease (n=2) (P=0.03). In conclusion, the recognition of different invasion patterns of metastatic extrauterine HGSC-BRCA has prognostic implications. The infiltrative micropapillary pattern is associated with poor outcomes and is more frequently seen in BRCA1-associated HGSC than in BRCA2 cases.</description><identifier>ISSN: 0147-5185</identifier><identifier>EISSN: 1532-0979</identifier><identifier>DOI: 10.1097/PAS.0000000000000556</identifier><identifier>PMID: 26574845</identifier><language>eng</language><publisher>United States: Copyright Wolters Kluwer Health, Inc. All rights reserved</publisher><subject>Adult ; Aged ; Biomarkers, Tumor - genetics ; Biopsy ; BRCA1 Protein - genetics ; BRCA2 Protein - genetics ; Carcinoma - genetics ; Carcinoma - mortality ; Carcinoma - secondary ; Carcinoma - therapy ; Disease Progression ; DNA Mutational Analysis ; Female ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Humans ; Middle Aged ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasms, Cystic, Mucinous, and Serous - genetics ; Neoplasms, Cystic, Mucinous, and Serous - mortality ; Neoplasms, Cystic, Mucinous, and Serous - secondary ; Neoplasms, Cystic, Mucinous, and Serous - therapy ; Phenotype ; Treatment Outcome ; Uterine Neoplasms - genetics ; Uterine Neoplasms - mortality ; Uterine Neoplasms - pathology ; Uterine Neoplasms - therapy</subject><ispartof>The American journal of surgical pathology, 2016-03, Vol.40 (3), p.404-409</ispartof><rights>Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5786-2fdac4e62a92e9fab937e531bcf1d7411fd887a4601637c9c58c89d6ffb162423</citedby><cites>FETCH-LOGICAL-c5786-2fdac4e62a92e9fab937e531bcf1d7411fd887a4601637c9c58c89d6ffb162423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26574845$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hussein, Yaser R</creatorcontrib><creatorcontrib>Ducie, Jennifer A</creatorcontrib><creatorcontrib>Arnold, Angela G</creatorcontrib><creatorcontrib>Kauff, Noah D</creatorcontrib><creatorcontrib>Vargas-Alvarez, Hebert A</creatorcontrib><creatorcontrib>Sala, Evis</creatorcontrib><creatorcontrib>Levine, Douglas A</creatorcontrib><creatorcontrib>Soslow, Robert A</creatorcontrib><title>Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes</title><title>The American journal of surgical pathology</title><addtitle>Am J Surg Pathol</addtitle><description>Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastatic HGSC-BRCA cases. Of the 37 cases of advanced-stage HGSC with known BRCA1 or BRCA2 germline mutation retrieved from our institutional files, 23 patients had a germline mutation of BRCA1 and 14 had a BRCA2 mutation. The pattern of invasion at metastatic sites was recorded and classified as a pushing pattern (either predominantly or exclusively), an exclusively micropapillary infiltrative pattern, or an infiltrative pattern composed of papillae, micropapillae, glands, and nests (mixed infiltrative pattern). Histologic evaluation of metastases was performed without knowledge of genotype or clinical outcome. Clinical data were abstracted from medical records. Median age was 56 years (range, 31 to 73 y). All patients presented at stage IIIC or IV and underwent complete surgical staging followed by chemotherapy. All 37 HGSC-BRCA cases showed either pushing pattern metastases (30; 81%) or infiltrative micropapillary metastases (7; 19%). No HGSC-BRCA case exhibited metastases composed solely of mixed infiltrative patterns. Among the 7 infiltrative micropapillary cases, 6 had a BRCA1 germline mutation versus 1 with a BRCA2 mutation. The median time of follow-up was 26 months (range, 13 to 49 mo). All 7 patients with infiltrative micropapillary metastases either experienced recurrence or died of disease (5 recurrences and 2 deaths), which was significantly worse than what was seen in patients with predominantly pushing pattern metastases, of whom 16 of 30 (53%) experienced recurrence (n=14) or died of disease (n=2) (P=0.03). In conclusion, the recognition of different invasion patterns of metastatic extrauterine HGSC-BRCA has prognostic implications. The infiltrative micropapillary pattern is associated with poor outcomes and is more frequently seen in BRCA1-associated HGSC than in BRCA2 cases.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biopsy</subject><subject>BRCA1 Protein - genetics</subject><subject>BRCA2 Protein - genetics</subject><subject>Carcinoma - genetics</subject><subject>Carcinoma - mortality</subject><subject>Carcinoma - secondary</subject><subject>Carcinoma - therapy</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Female</subject><subject>Genetic Predisposition to Disease</subject><subject>Germ-Line Mutation</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Invasiveness</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - genetics</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - mortality</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - secondary</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - therapy</subject><subject>Phenotype</subject><subject>Treatment Outcome</subject><subject>Uterine Neoplasms - genetics</subject><subject>Uterine Neoplasms - mortality</subject><subject>Uterine Neoplasms - pathology</subject><subject>Uterine Neoplasms - therapy</subject><issn>0147-5185</issn><issn>1532-0979</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9OFTEUhxujkSv4BsZ06WZw2umfmY3JdYJAAoEIhGXT2zlzp9qZYtsBeQZe2l4vEnRhN01zvvOdtj-E3pFyn5SN_Hi-vNgvny_OxQu0ILyiRa43L9GiJEwWnNR8B72J8VtZEloT-hrtUMElqxlfoIfj6VZH6yd8rlOCMEXse3wKScekkzX44GcKes4VOwE-suuhWAfdAb6A4OeIWx2Mnfyo8bVNA_78tV3iQwij2-Cn88aR3XrqcOtDALc9_2bbzFijHT6bk_EjxD30qtcuwtvHfRddfTm4bI-Kk7PD43Z5Uhgua1HQvtOGgaC6odD0etVUEnhFVqYnnWSE9F1dS81ESUQlTWN4beqmE32_IoIyWu2iT1vvzbwaoTMw5Sc6dRPsqMO98tqqvyuTHdTa3yrWyJJRkQUfHgXB_5ghJjXaaMA5PUH-FEWk4ITQpuIZZVvUBB9jgP5pDCnVJkeVc1T_5pjb3j-_4lPTn-AyUG-BO-9yOPG7m-8gqAG0S8P_3b8An6etBA</recordid><startdate>201603</startdate><enddate>201603</enddate><creator>Hussein, Yaser R</creator><creator>Ducie, Jennifer A</creator><creator>Arnold, Angela G</creator><creator>Kauff, Noah D</creator><creator>Vargas-Alvarez, Hebert A</creator><creator>Sala, Evis</creator><creator>Levine, Douglas A</creator><creator>Soslow, Robert A</creator><general>Copyright Wolters Kluwer Health, Inc. All rights reserved</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201603</creationdate><title>Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes</title><author>Hussein, Yaser R ; Ducie, Jennifer A ; Arnold, Angela G ; Kauff, Noah D ; Vargas-Alvarez, Hebert A ; Sala, Evis ; Levine, Douglas A ; Soslow, Robert A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5786-2fdac4e62a92e9fab937e531bcf1d7411fd887a4601637c9c58c89d6ffb162423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biopsy</topic><topic>BRCA1 Protein - genetics</topic><topic>BRCA2 Protein - genetics</topic><topic>Carcinoma - genetics</topic><topic>Carcinoma - mortality</topic><topic>Carcinoma - secondary</topic><topic>Carcinoma - therapy</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Female</topic><topic>Genetic Predisposition to Disease</topic><topic>Germ-Line Mutation</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Invasiveness</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - genetics</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - mortality</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - secondary</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - therapy</topic><topic>Phenotype</topic><topic>Treatment Outcome</topic><topic>Uterine Neoplasms - genetics</topic><topic>Uterine Neoplasms - mortality</topic><topic>Uterine Neoplasms - pathology</topic><topic>Uterine Neoplasms - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussein, Yaser R</creatorcontrib><creatorcontrib>Ducie, Jennifer A</creatorcontrib><creatorcontrib>Arnold, Angela G</creatorcontrib><creatorcontrib>Kauff, Noah D</creatorcontrib><creatorcontrib>Vargas-Alvarez, Hebert A</creatorcontrib><creatorcontrib>Sala, Evis</creatorcontrib><creatorcontrib>Levine, Douglas A</creatorcontrib><creatorcontrib>Soslow, Robert A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The American journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussein, Yaser R</au><au>Ducie, Jennifer A</au><au>Arnold, Angela G</au><au>Kauff, Noah D</au><au>Vargas-Alvarez, Hebert A</au><au>Sala, Evis</au><au>Levine, Douglas A</au><au>Soslow, Robert A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes</atitle><jtitle>The American journal of surgical pathology</jtitle><addtitle>Am J Surg Pathol</addtitle><date>2016-03</date><risdate>2016</risdate><volume>40</volume><issue>3</issue><spage>404</spage><epage>409</epage><pages>404-409</pages><issn>0147-5185</issn><eissn>1532-0979</eissn><abstract>Characteristic histopathologic features have been described in high-grade serous carcinoma associated with BRCA abnormalities (HGSC-BRCA), which are known to have relatively favorable clinical outcomes. The aim of this study was to evaluate the clinical significance of invasion patterns in metastatic HGSC-BRCA cases. Of the 37 cases of advanced-stage HGSC with known BRCA1 or BRCA2 germline mutation retrieved from our institutional files, 23 patients had a germline mutation of BRCA1 and 14 had a BRCA2 mutation. The pattern of invasion at metastatic sites was recorded and classified as a pushing pattern (either predominantly or exclusively), an exclusively micropapillary infiltrative pattern, or an infiltrative pattern composed of papillae, micropapillae, glands, and nests (mixed infiltrative pattern). Histologic evaluation of metastases was performed without knowledge of genotype or clinical outcome. Clinical data were abstracted from medical records. Median age was 56 years (range, 31 to 73 y). All patients presented at stage IIIC or IV and underwent complete surgical staging followed by chemotherapy. All 37 HGSC-BRCA cases showed either pushing pattern metastases (30; 81%) or infiltrative micropapillary metastases (7; 19%). No HGSC-BRCA case exhibited metastases composed solely of mixed infiltrative patterns. Among the 7 infiltrative micropapillary cases, 6 had a BRCA1 germline mutation versus 1 with a BRCA2 mutation. The median time of follow-up was 26 months (range, 13 to 49 mo). All 7 patients with infiltrative micropapillary metastases either experienced recurrence or died of disease (5 recurrences and 2 deaths), which was significantly worse than what was seen in patients with predominantly pushing pattern metastases, of whom 16 of 30 (53%) experienced recurrence (n=14) or died of disease (n=2) (P=0.03). In conclusion, the recognition of different invasion patterns of metastatic extrauterine HGSC-BRCA has prognostic implications. The infiltrative micropapillary pattern is associated with poor outcomes and is more frequently seen in BRCA1-associated HGSC than in BRCA2 cases.</abstract><cop>United States</cop><pub>Copyright Wolters Kluwer Health, Inc. All rights reserved</pub><pmid>26574845</pmid><doi>10.1097/PAS.0000000000000556</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0147-5185 |
ispartof | The American journal of surgical pathology, 2016-03, Vol.40 (3), p.404-409 |
issn | 0147-5185 1532-0979 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4970426 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Adult Aged Biomarkers, Tumor - genetics Biopsy BRCA1 Protein - genetics BRCA2 Protein - genetics Carcinoma - genetics Carcinoma - mortality Carcinoma - secondary Carcinoma - therapy Disease Progression DNA Mutational Analysis Female Genetic Predisposition to Disease Germ-Line Mutation Humans Middle Aged Neoplasm Grading Neoplasm Invasiveness Neoplasms, Cystic, Mucinous, and Serous - genetics Neoplasms, Cystic, Mucinous, and Serous - mortality Neoplasms, Cystic, Mucinous, and Serous - secondary Neoplasms, Cystic, Mucinous, and Serous - therapy Phenotype Treatment Outcome Uterine Neoplasms - genetics Uterine Neoplasms - mortality Uterine Neoplasms - pathology Uterine Neoplasms - therapy |
title | Invasion Patterns of Metastatic Extrauterine High-grade Serous Carcinoma With BRCA Germline Mutation and Correlation With Clinical Outcomes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T11%3A52%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Invasion%20Patterns%20of%20Metastatic%20Extrauterine%20High-grade%20Serous%20Carcinoma%20With%20BRCA%20Germline%20Mutation%20and%20Correlation%20With%20Clinical%20Outcomes&rft.jtitle=The%20American%20journal%20of%20surgical%20pathology&rft.au=Hussein,%20Yaser%20R&rft.date=2016-03&rft.volume=40&rft.issue=3&rft.spage=404&rft.epage=409&rft.pages=404-409&rft.issn=0147-5185&rft.eissn=1532-0979&rft_id=info:doi/10.1097/PAS.0000000000000556&rft_dat=%3Cproquest_pubme%3E1765112935%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1765112935&rft_id=info:pmid/26574845&rfr_iscdi=true |